TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Sta...(tend to update publicly any forward-look...),Health

Date:12/3/2007

tend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.

'/>"/>

SOURCE Cephalon, Inc. Copyright©2007 PR Newswire. All rights reserved

3 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Investigational New Drug Application for Fat Melting Injections Cleared by the FDA
4. PreMD Provides Update on 510(k) Application for PREVU(x) POC
5. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. PartsSource Awarded US Patent for PartsFinder(TM) Application
9. HealthCentral.com Launches Greeting Card Application on Facebook.com
10. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
11. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125